UA50329A - Method for treating primary erysipelas - Google Patents

Method for treating primary erysipelas

Info

Publication number
UA50329A
UA50329A UA2001128896A UA2001128896A UA50329A UA 50329 A UA50329 A UA 50329A UA 2001128896 A UA2001128896 A UA 2001128896A UA 2001128896 A UA2001128896 A UA 2001128896A UA 50329 A UA50329 A UA 50329A
Authority
UA
Ukraine
Prior art keywords
treating primary
erysipelas
cycloferon
primary erysipelas
treating
Prior art date
Application number
UA2001128896A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Валерій Митрофанович Фролов
Валерий Митрофанович Фролов
Анатолій Данилович Старік
Ігор Іванович Зельоний
Игорь Иванович Зеленый
Original Assignee
Валерій Митрофанович Фролов
Валерий Митрофанович Фролов
Анатолій Данилович Старік
Ігор Іванович Зельоний
Игорь Иванович Зеленый
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валерій Митрофанович Фролов, Валерий Митрофанович Фролов, Анатолій Данилович Старік, Ігор Іванович Зельоний, Игорь Иванович Зеленый filed Critical Валерій Митрофанович Фролов
Priority to UA2001128896A priority Critical patent/UA50329A/en
Publication of UA50329A publication Critical patent/UA50329A/en

Links

Abstract

The method for treating the primary erysipelas comprises the antibacterial and antihistamine treatment, physiotherapy as well as such drugs as ascorhutin, amison, and cycloferon. Cycloferon as 12.5% solution is injected intramuscularly at a dose of 2 ml once a day for 5-10 days.
UA2001128896A 2001-12-21 2001-12-21 Method for treating primary erysipelas UA50329A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2001128896A UA50329A (en) 2001-12-21 2001-12-21 Method for treating primary erysipelas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2001128896A UA50329A (en) 2001-12-21 2001-12-21 Method for treating primary erysipelas

Publications (1)

Publication Number Publication Date
UA50329A true UA50329A (en) 2002-10-15

Family

ID=74235298

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001128896A UA50329A (en) 2001-12-21 2001-12-21 Method for treating primary erysipelas

Country Status (1)

Country Link
UA (1) UA50329A (en)

Similar Documents

Publication Publication Date Title
WO2002056912A3 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
ATE339406T1 (en) CHINAZOLINE COMPOUNDS AS REMEDIES
GB0225475D0 (en) Therapeutic agents
NO954996L (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
MXPA03003960A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders.
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
NO20013680L (en) Ketolidantibiotika
MXPA03008623A (en) Pharmaceutical combinations for the treatment of cancer.
MY119375A (en) Treatment of tinnitus using neuroprotective agents
MXPA04005156A (en) Adenosine a2a.
GT199900208A (en) CARBAMATO AND CARBAZATO CETÒLID ANTIBIOTICS.
GB0222514D0 (en) Organic compounds
HK1068606A1 (en) Novel aminobenzoephenones
GB0130677D0 (en) Medicaments and novel compounds
AP1749A (en) Method of treating of demyelinating diseases or conditions.
AP1729A (en) Single dose azithromycin for treating respiratory infections.
GB9907571D0 (en) Compounds
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
TR200402230T4 (en) O-substituted 6-methyl-tramadol derivatives
EA199800864A1 (en) METHOD OF TREATMENT FOR PATIENTS CAUSED BY MIGRAINE
EP0869786A4 (en) Pharmaceutical compounds
UA50329A (en) Method for treating primary erysipelas
HUP0000110A2 (en) Pharmaceutical compositions comprising azacyclic, azabicyclic or tetrahydro-pyridine-derivatives suitable for treating pain
MXPA03006359A (en) Method for treating cancer having greater efficacy and reduced adverse effects.
BR0308911A (en) Compound, pharmaceutical composition, pain and migraine treatment methods, and use of a compound